Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Thyroid Neoplasms × combretastatin × Clear all

Phase

Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1

Interventions

fosbretabulin 1 combretastatin 1 Sodium Iodide 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Iodine-131 1 Iodine-123 1 Dexmedetomidine 1 Carboplatin 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00507429 2014-06-09

FACT

Mateon Therapeutics

Phase 2/3 Terminated

80 enrolled 10 charts

EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡